PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NVNO vs. PANW
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NVNO and PANW is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

NVNO vs. PANW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in enVVeno Medical Corporation (NVNO) and Palo Alto Networks, Inc. (PANW). The values are adjusted to include any dividend payments, if applicable.

-60.00%-40.00%-20.00%0.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-43.75%
7.09%
NVNO
PANW

Key characteristics

Sharpe Ratio

NVNO:

-0.32

PANW:

0.16

Sortino Ratio

NVNO:

-0.04

PANW:

0.48

Omega Ratio

NVNO:

1.00

PANW:

1.08

Calmar Ratio

NVNO:

-0.22

PANW:

0.22

Martin Ratio

NVNO:

-0.64

PANW:

0.45

Ulcer Index

NVNO:

33.06%

PANW:

14.79%

Daily Std Dev

NVNO:

66.02%

PANW:

43.25%

Max Drawdown

NVNO:

-98.10%

PANW:

-47.98%

Current Drawdown

NVNO:

-97.57%

PANW:

-12.70%

Fundamentals

Market Cap

NVNO:

$55.59M

PANW:

$114.30B

EPS

NVNO:

-$1.29

PANW:

$3.85

Total Revenue (TTM)

NVNO:

$0.00

PANW:

$8.29B

Gross Profit (TTM)

NVNO:

-$406.00K

PANW:

$6.15B

EBITDA (TTM)

NVNO:

-$16.72M

PANW:

$1.40B

Returns By Period

In the year-to-date period, NVNO achieves a 5.30% return, which is significantly higher than PANW's -2.63% return.


NVNO

YTD

5.30%

1M

13.98%

6M

-44.79%

1Y

-21.09%

5Y*

-26.70%

10Y*

N/A

PANW

YTD

-2.63%

1M

-11.96%

6M

9.40%

1Y

7.36%

5Y*

34.56%

10Y*

23.92%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NVNO vs. PANW — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVNO
The Risk-Adjusted Performance Rank of NVNO is 3232
Overall Rank
The Sharpe Ratio Rank of NVNO is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of NVNO is 3232
Sortino Ratio Rank
The Omega Ratio Rank of NVNO is 3232
Omega Ratio Rank
The Calmar Ratio Rank of NVNO is 3434
Calmar Ratio Rank
The Martin Ratio Rank of NVNO is 3434
Martin Ratio Rank

PANW
The Risk-Adjusted Performance Rank of PANW is 5252
Overall Rank
The Sharpe Ratio Rank of PANW is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of PANW is 4646
Sortino Ratio Rank
The Omega Ratio Rank of PANW is 5050
Omega Ratio Rank
The Calmar Ratio Rank of PANW is 5757
Calmar Ratio Rank
The Martin Ratio Rank of PANW is 5353
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NVNO vs. PANW - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for enVVeno Medical Corporation (NVNO) and Palo Alto Networks, Inc. (PANW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NVNO, currently valued at -0.32, compared to the broader market-2.000.002.00-0.320.16
The chart of Sortino ratio for NVNO, currently valued at -0.04, compared to the broader market-4.00-2.000.002.004.006.00-0.040.48
The chart of Omega ratio for NVNO, currently valued at 1.00, compared to the broader market0.501.001.502.001.001.08
The chart of Calmar ratio for NVNO, currently valued at -0.21, compared to the broader market0.002.004.006.00-0.220.22
The chart of Martin ratio for NVNO, currently valued at -0.64, compared to the broader market-10.000.0010.0020.0030.00-0.640.45
NVNO
PANW

The current NVNO Sharpe Ratio is -0.32, which is lower than the PANW Sharpe Ratio of 0.16. The chart below compares the historical Sharpe Ratios of NVNO and PANW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
-0.32
0.16
NVNO
PANW

Dividends

NVNO vs. PANW - Dividend Comparison

Neither NVNO nor PANW has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NVNO vs. PANW - Drawdown Comparison

The maximum NVNO drawdown since its inception was -98.10%, which is greater than PANW's maximum drawdown of -47.98%. Use the drawdown chart below to compare losses from any high point for NVNO and PANW. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-97.57%
-12.70%
NVNO
PANW

Volatility

NVNO vs. PANW - Volatility Comparison

enVVeno Medical Corporation (NVNO) has a higher volatility of 23.54% compared to Palo Alto Networks, Inc. (PANW) at 9.58%. This indicates that NVNO's price experiences larger fluctuations and is considered to be riskier than PANW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%AugustSeptemberOctoberNovemberDecember2025
23.54%
9.58%
NVNO
PANW

Financials

NVNO vs. PANW - Financials Comparison

This section allows you to compare key financial metrics between enVVeno Medical Corporation and Palo Alto Networks, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab